<DOC>
	<DOCNO>NCT02289989</DOCNO>
	<brief_summary>This study design evaluate compare efficacy 3 % oregano extract ointment prepare aqueous solution versus 1 % hydrocortisone ointment , standard treatment , decrease inflammation associate mild moderate atopic dermatitis . We plan recruit 40 patient age comprise 2 17 year old study duration patient 1 month .</brief_summary>
	<brief_title>Oregano Ointment vs. Standard Treatment Pediatric Atopic Dermatitis</brief_title>
	<detailed_description>A single-center , investigator initiate , randomize control , double-blind trial conduct determine effect oregano extract aqueous solution versus 1 % hydrocortisone treatment acute-subacute pediatric AD . We suspect topical oregano serve effective , non-steroidal AD therapy , simultaneously offer extra benefit pediatric patient oregano natural product antimicrobial , anti-inflammatory , antiseptic property lack report adverse effect associate steroid , child note susceptible .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Male nonpregnant female subject age 217 year age . Individuals must diagnose acutesubacute AD regardless study . Written informed consent must obtain patient caregiver . Women childbearing potential ( WOCBP ) must willing practice effective contraception duration study treatment . Subjects must willing able comply study condition , properly apply caregiver apply topical medication select body site , well return clinic require visit . Subject caregiver must willing able perform ADQ assessment test . Individuals immunecompromised suffer infectious disease , malignant disease , know HIV+ present general reduce level health . Individuals diagnose underlie dermatological condition addition AD . Individuals chronic preexisting disease diabetes mellitus others opinion investigator would preclude participation study . Individuals pregnant , nursing mother , subject plan pregnancy course study . Subjects/caregivers unable communicate comply study condition due language disability , poor mental development , impaired cerebral function . Individuals simultaneously enrol another clinical drug device research study . Individuals history chronic steroid use . Individuals need concurrently use topical agent , medicinal product contain corticosteroid , immunosuppressant . Individuals receive systemically administer corticosteroid and/or antihistamine 2 week prior start study . Individuals undergo light therapy . Individuals treat another investigation device drug within 30 day prior study enrollment . Individuals know allergy oregano .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Atopic dermatitis</keyword>
	<keyword>Oregano</keyword>
	<keyword>ADQ score</keyword>
	<keyword>EASI score</keyword>
	<keyword>Reflectance confocal microscopy</keyword>
</DOC>